Association of Azvudine with severe outcomes among hospitalized patients with COVID-19 during an omicron-dominance period in Wuhan, China: a single-center, retrospective, matched cohort study. [PDF]
BMC Infect DisGuo Z +11 more
europepmc +1 more source
Population Pharmacokinetic Modeling Analysis of ASC10, a Novel Antiviral Agent Targeted COVID-19, in Chinese Healthy Subjects [PDF]
Duo Lv,1,2,* Sichan Li,3,* Yi Li,4 Meihua Lin,1,2 You Zhai,1,2 Meijia Wu,1,2 Yunqing Qiu,1,2 Qingwei Zhao,1,2 Jian Liu1,2 1Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou ...
Li S +8 more
core +1 more source
Actualización del uso de antivirales para el tratamiento de la Covid-19 [PDF]
, 2021 Cabral, Santiago +3 more
core +2 more sources
Editorial: Toxicity mechanisms, exposure, toxicokinetic and risk assessment aspects of metals, toxic for animals and humans, volume III. [PDF]
Front PharmacolZhu Y +5 more
europepmc +1 more source
Factors Influencing COVID-19 Viral Clearance: Implications for Vaccination and Antiviral Therapy. [PDF]
Infect Drug ResistZeng J +13 more
europepmc +1 more source
Agent Hospital: A Simulacrum of Hospital with Evolvable Medical Agents
In this paper, we introduce a simulacrum of hospital called Agent Hospital that simulates the entire process of treating illness. All patients, nurses, and doctors are autonomous agents powered by large language models (LLMs).
Kang, Xinhui +7 more
core
Editorial: The evolution in pharmacology of infectious diseases: 2022 [PDF]
Kalesh, Karunakaran +2 more
core
Editorial: Emerging concepts for respiratory viruses after the pandemic. [PDF]
Front Cell Infect MicrobiolDimopoulou D +4 more
europepmc +1 more source
Efficacy of Azvudine Therapy in Patients with Severe and Non-Severe COVID-19: A Propensity Score-Matched Analysis. [PDF]
Infect Drug ResistZhang S +6 more
europepmc +1 more source